BioCorRx BICX
OTC BICX
$0.25 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

BioCorRx (BICX) Current Debt (2015)

Updated

BioCorRx (BICX) recorded Current Debt of $58,000 in FY2012.

Analysis

BioCorRx (BICX) Current Debt (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -5.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 64.00 Mn
10 BioCorRx 4.32 Mn 3.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 47,500.00
API Access

BioCorRx Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BICX&period=max&api_key=YOUR_API_KEY